Evaluation of plasma C-terminal atrial natriuretic peptide in healthy cats and cats with heart disease

Journal of Veterinary Internal Medicine

Volumn 22, Issue 1, 2008, Pages 135-139

  Hori, Y ^a   Yamano, S ^b,c   Iwanaga, K ^d   Kano, T ^a   Tanabe, M ^a   Uechi, M ^c   Kanai, K ^a   Nakao, R ^a   Hoshi, F ^a   Higuchi, S ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Kanie Animal Clinic   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

C terminal atrial natriuretic peptide; Cardiomyopathy; Cats; Left atrial pressure

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE CONTROL STUDY; CAT; CAT DISEASE; FEMALE; HEART DISEASE; HEMODYNAMICS; MALE; PATHOPHYSIOLOGY;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; CAT DISEASES; CATS; FEMALE; HEART DISEASES; HEMODYNAMICS; MALE;

ANIMALIA;

EID: 40549104169     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2007.0007.x     Document Type: Article

References (24)

1. Heringer-Walther S, Moreira Mda C, Wessel N, et al. Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies? J Cardiovasc Pharmacol 2006;48:293-298.
2. O'Sullivan ML, O'Grady MR, Minors SL. Plasma big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrine concentrations in normal Doberman Pinschers and Doberman Pinschers with dilated cardiomyopathy. J Vet Intern Med 2007;21:92-99.
3. Oyama MA, Sisson DD. Cardiac troponin-I concentration in dogs with cardiac disease. J Vet Intern Med 2004;18:831-839.
4. Oyama MA, Sisson DD, Solter PF. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-1 concentrations. Am J Vet Res 2007;68:42-47.
5. Biondo AW, Liu ZL, Wiedmeyer CE, et al. Genomic sequence and cardiac expression of atrial natriuretic peptide in cats. Am J Vet Res 2002;63:236-240.
6. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003;24:341-356, (review).
7. Gottlieb SS, Kukin ML, Ahern D, et al. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989;13:1534-1539.
8. Grzybowski J, Bilinska ZT, Janas J, et al. Plasma concentrations of N-terminal atrial natriuretic peptide are raised in asymptomatic relatives of dilated cardiomyopathy patients with left ventricular enlargement. Heart 2002;88:191-192.
9. Rouleau JL, Packer M, Moye L, et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captopril. J Am Coll Cardiol 1994;24:583-591.
10. Asano K, Masuda K, Okumura M, et al. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. J Vet Med Sci 1999;61:523-529.
11. Cheung MM, Smallhorn JF, Redington AN, et al. The effects of changes in loading conditions and modulation of inotropic state on the myocardial performance index: Comparison with conductance catheter measurements. Eur Heart J 2004;25:2238-2242.
12. Fox SM. Textbook of Canine and Feline Cardiology, 2nd ed. Philadelphia: WB Saunders Company; 1999.
13. Fox PR, Lui SK, Maron BJ. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease. Circulation 1995;92:2645-2651.
14. Nelson RW, Couto CG. Small Animal Internal Medicine, 3rd ed. St Louis: Mosby; 2003.
15. Ferasin L, Sturgess CP, Cannon MJ, et al. Feline idiopathic cardiomyopathy: A retrospective study of 106 cats (1994-2001). J Feline Med Surg 2003;5:151-159.
16. Harada K, Tamura M, Toyono M, et al. Effect of dobutamine on a Doppler echocardiographic index of combined systolic and diastolic performance. Pediatr Cardiol 2002;23:613-617.
17. Dzimiri N, Moorji A, Afrane B, et al. Differential regulation of atrial and brain natriuretic peptides and its implications for the management of left ventricular volume overload. Eur J Clin Invest 2002;32:563-569.
18. Borgeson DD, Stevens TL, Heublein DM, et al. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: Functional cardiorenal responses to receptor antagonism. Clin Sci (London) 1998;95:195-202.
19. Biondo AW, Ehrhart EJ, Sisson DD, et al. Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy. Vet Pathol 2003;40:501-506.
20. Matsumoto N, Akaike M, Nishiuchi T, et al. Different secretion profiles of atrial and brain natriuretic peptides after acute volume loading in patients with ischemic heart disease. Acta Cardiol 1997;52:261-272.
21. Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:1508-1515.
22. Greco DS, Biller B, Van Liew CH. Measurement of plasma atrial natriuretic peptide as an indicator of prognosis in dogs with cardiac disease. Can Vet J 2003;44:293-297.
23. MacLean HN, Abbott JA, Ward DL, et al. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. J Vet Intern Med 2006;20:284-289.
24. Holmstrom H, Hall C, Stokke TO, et al. Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age. Scand J Clin Lab Invest 2000;60:149-159.